Viatris settles lawsuit over use of woman's 'immortal' cells to power drug research [Yahoo! Finance]
Viatris Inc. (VTRS)
Company Research
Source: Yahoo! Finance
woman whose ?tissue samples were used without her permission to develop enduring cells ?for lucrative medical research. Viatris and Lacks' estate told a federal court in Baltimore, Maryland, on Wednesday ?that they would dismiss the case with prejudice, which means it cannot be refiled. An attorney for Lacks' estate said her family was "pleased the parties were able to find a way to resolve this matter" and that details of the settlement were ?confidential. Spokespeople for Viatris ?did not immediately respond to a request for comment and more information. Lacks' family has filed several lawsuits seeking to recover profits ?from the unauthorized use of her cells for drug research. Her estate settled a related lawsuit against Novartis in February, resolved another case against Thermo Fisher in 2023 ?and ?filed a similar lawsuit against Ultragenyx that ?is still ongoing. Lacks, a Black woman ?whose story was told in the best-selling book "The Immortal Life of Henrietta Lacks," s
Show less
Read more
Impact Snapshot
Event Time:
VTRS
Last Price
Price Change
Price Change%
Volume Shares
Max Up
Max Down
%
Volume Ratio
Performance Comparison
Updated
|
Event Day
Stock performance from the time of news release until the following 4pm ET market close
|
Last price at news event
|
Since Event
Multi-day stock performance from the time of the news release
|
|---|---|---|
|
EVENT DAY
Stock performance from the time of news release until the following 4pm ET market close
|
LAST
PRICE AT NEWS EVENT |
SINCE EVENT
Multi-day stock performance from the time of the news release
|
| Last Price | ||
| VWAP | ||
|
High:
|
Max Up |
High:
|
|
Low:
|
Max Down |
Low:
|
|
%
|
Post news range |
%
|
|
|
Price change |
|
|
|
Price Change Percentage |
|
|
|
S&P 500 (SPX) |
|
|
%
|
Volume ratio |
%
|
| Volume | ||
| Ticks | ||
|
|
Avg transaction size |
|
Don't Miss Out On The Next BIG Stock Move
Event day
Event Day Chart will not be displayed beyond 90-day period of the event
Performance since event
Time And Velocity Analysis
Be the first to know
Opt in for alerts from News Quantifed
Sign Up Today
Opt-in for
VTRS alerts
Learn More With NQ
Reading the Impact Report
Help Me Understand This Data
Help Me Understand This Data
How NQ Works
What is news-based trading?
And why is it so successful?
And why is it so successful?
Movers & Shakers
The biggest gainers and losers and WHY it moved
VTRS alerts
High impacting Viatris Inc. news events
Weekly update
A roundup of the hottest topics
VTRS
News
- UBS and BofA Lift Price Targets on Viatris (VTRS) [Yahoo! Finance]Yahoo! Finance
- GoodRx to offer up to 85% discount on Viatris drugs [Seeking Alpha]Seeking Alpha
- Viatris (VTRS): Buy, Sell, or Hold Post Q4 Earnings? [Yahoo! Finance]Yahoo! Finance
- Viatris (VTRS) Delivers Solid 2025 Growth and Robust Cash Flow at Deep Value [Yahoo! Finance]Yahoo! Finance
- UBS Raises Viatris (VTRS) Price Target as Cost Savings and Growth Outlook Improve [Yahoo! Finance]Yahoo! Finance
VTRS
Earnings
- 2/26/26 - Beat
VTRS
Sec Filings
- 3/10/26 - Form 4
- 3/10/26 - Form 4
- 3/10/26 - Form 4
- VTRS's page on the SEC website